PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study is a paper indexed in PICO Portal from OpenAlex.
How many citations does PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study have?
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study has 186 citations in the OpenAlex counts PICO Portal stores.
When was PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study published?
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study has 2016 year in the PICO Portal index.
What is the open-access status of PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study?
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study has bronze oa status in the PICO Portal index.
What is the DOI of PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study?
The DOI for PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study is on the source record.
What is the PMID of PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study?
The PMID for PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study is on the source record.
What is the OpenAlex record for PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study?
The OpenAlex for PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study is on the source record.